Join
Live feed
·
INSIDERFilingvia Quantisnow
Milestone Pharmaceuticals Inc. logo

Chief Commercial Officer Muller Lorenz converted options into 20,100 shares, was granted 100,000 shares and sold $145,851 worth of shares (64,746 units at $2.25), increasing direct ownership by 37% to 205,406 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MIST (Milestone Pharmaceuticals Inc.) and more on Quantisnow.